MedTech / BioTech

MiRXES is a privately-held life science research tool provider and miRNA diagnostic test developer headquartered in Singapore. MiRXES specializes in providing clinical diagnostic tools that seek to revolutionize early cancer detection in clinical examinations with its best-in-class MicroRNA quantification platform. MiREXS was founded in 2014 with the vision of creating accurate, affordable and actionable molecular diagnostic tests to improve cancer management. It is a spin-off enterprise from the Bioprocessing Technology Institute of the Agency of Science, Technology and Research (A*STAR) and is a key partner of Singapore’s National Diagnostic Initiative.

Back to Portfolio
  • Founders: Professor Too Heng-Phon, Dr Zhou Li Han,  Dr Zou Ruiyang
  • Year founded: 2004
  • Headquarter: Singapore

© All rights reserved, powered by Venturecraft. Designed by Muzi Creative.